Pro erlotinib

Date 28 June 2014
Event 4th International Conference on Thoracic Oncology
Session Face to face II - Second-line treatment of NSCLC EGFR WT: the erlotinib vs chemotherapy debate 2 years later
Topics Anti-Cancer Agents & Biologic Therapy
Non-Small-Cell Lung Cancer, Metastatic
Presenter F. de Marinis